American Century Companies’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-479,263
Closed -$18.9M 2926
2023
Q2
$18.9M Sell
479,263
-3,565,655
-88% -$126M 0.01% 802
2023
Q1
$98.4M Buy
4,044,918
+2,713,544
+204% +$59.4M 0.08% 281
2022
Q4
$28.5M Buy
+1,331,374
New +$28.4M 0.02% 596
2016
Q4
Sell
-38,005
Closed -$1.75M 1428
2016
Q3
$1.75M Buy
38,005
+8,207
+28% +$463K ﹤0.01% 1076
2016
Q2
$1.52M Buy
29,798
+7,870
+36% +$391K ﹤0.01% 1072
2016
Q1
$927K Buy
+21,928
New +$1.12M ﹤0.01% 1116
2015
Q4
Sell
-88,173
Closed -$3.57M 1408
2015
Q3
$3.57M Sell
88,173
-94,954
-52% -$5.03M ﹤0.01% 916
2015
Q2
$9.53M Buy
183,127
+98,081
+115% +$4.88M 0.01% 685
2015
Q1
$3.96M Sell
85,046
-5,600
-6% -$291K ﹤0.01% 911
2014
Q4
$4.07M Buy
+90,646
New +$3.81M ﹤0.01% 917

American Century Companies's ISEE Position: Q3 2023 in Review

American Century Companies sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 479,263 shares — an estimated $18.9M sold.

American Century Companies first reported a position in ISEE in Q4 2014 and held it in 10 quarters. The position peaked at $98.4M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • American Century Companies reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • American Century Companies sold 479,263 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $18.9M.
  • American Century Companies first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 10 quarters.
  • American Century Companies's IVERIC bio, Inc. Common Stock position peaked at $98.4M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.